1 July 2024 false No description of principal activity Taxfiler 2024.6 10227499business:CompanyLimitedByGuarantee2024-07-012025-06-30 102274992024-06-30 102274992024-07-012025-06-30 10227499business:AuditExemptWithAccountantsReport2024-07-012025-06-30 10227499business:FilletedAccounts2024-07-012025-06-30 102274992025-06-30 10227499business:Director12024-07-012025-06-30 10227499business:Director22024-07-012025-06-30 10227499business:RegisteredOffice2024-07-012025-06-30 102274992024-06-30 10227499core:WithinOneYear2025-06-30 10227499core:WithinOneYear2024-06-30 10227499core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-06-30 10227499core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-06-30 10227499core:PreviouslyStatedAmount2025-06-30 10227499core:PreviouslyStatedAmount2024-06-30 10227499business:SmallEntities2024-07-012025-06-30 10227499countries:EnglandWales2024-07-012025-06-30 10227499core:ComputerEquipment2024-07-012025-06-30 10227499core:ComputerEquipment2024-06-30 10227499core:ComputerEquipment2025-06-30 102274992023-07-012024-06-30 iso4217:GBP xbrli:pure
Company Registration No. 10227499 (England and Wales)
U.K. Medical Development Associates Unaudited accounts for the year ended 30 June 2025
U.K. Medical Development Associates Unaudited accounts Contents
Page
- 2 -
U.K. Medical Development Associates Company Information for the year ended 30 June 2025
Directors
Mr Jiqing Yang Dr. Wei Juan Zhang
Company Number
10227499 (England and Wales)
Registered Office
81 Nonsuch Walk Cheam Surrey SM2 7LF
Accountants
Blythe & Co 41 Oldfields Road Sutton Surrey SM1 2NB
- 3 -
U.K. Medical Development Associates Statement of financial position as at 30 June 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
2,047 
- 
Current assets
Debtors
57,220 
33,783 
Cash at bank and in hand
18,182 
144,906 
75,402 
178,689 
Creditors: amounts falling due within one year
(6,942)
(150,770)
Net current assets
68,460 
27,919 
Net assets
70,507 
27,919 
Reserves
Profit and loss account
70,507 
27,919 
Members' funds
70,507 
27,919 
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 June 2025 and were signed on its behalf by
Mr Jiqing Yang Director Company Registration No. 10227499
- 4 -
U.K. Medical Development Associates Notes to the Accounts for the year ended 30 June 2025
1
Statutory information
U.K. Medical Development Associates is a private company, limited by guarantee, registered in England and Wales, registration number 10227499. The registered office is 81 Nonsuch Walk, Cheam, Surrey, SM2 7LF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
4 Years
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 July 2024
- 
Additions
2,472 
At 30 June 2025
2,472 
Depreciation
Charge for the year
425 
At 30 June 2025
425 
Net book value
At 30 June 2025
2,047 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Other debtors
57,220 
33,783 
- 5 -
U.K. Medical Development Associates Notes to the Accounts for the year ended 30 June 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
- 
148,500 
Taxes and social security
6,142 
1,470 
Accruals
800 
800 
6,942 
150,770 
7
Company limited by guarantee
The company is limited by guarantee and has no share capital. Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -